Related Experiment Videos
Brain atrophy in Huntington's disease. A CT-scan study
S E Starkstein1, S E Folstein, J Brandt
1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore.
Neuroradiology
|January 1, 1989
Summary
Brain imaging in Huntington
Area of Science:
- Neuroimaging
- Neurology
- Medical Imaging
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- Assessing brain atrophy is crucial for understanding HD progression.
Purpose of the Study:
- To investigate the relationship between cortical and subcortical atrophy and disease progression in Huntington's disease.
- To identify sensitive imaging markers for early detection of HD.
Main Methods:
- Computed tomography (CT) scans were performed on 34 Huntington's disease patients.
- Measurements of cortical and subcortical atrophy ratios were analyzed.
- HD patient data were compared with age-matched healthy controls.
Main Results:
- Subcortical atrophy correlated with disease duration, while cortical atrophy correlated with age.
- The bicaudate ratio demonstrated the highest sensitivity and specificity in distinguishing HD patients from controls.
- Mildly affected patients showed elevated bicaudate ratios compared to controls.
Conclusions:
- Different patterns of atrophy (cortical vs. subcortical) relate to distinct disease progression factors (age vs. duration).
- The bicaudate ratio is a highly sensitive imaging biomarker for detecting Huntington's disease, even in early stages.